Literature DB >> 16875084

Blood transfusion is associated with infection and increased resource utilization in combat casualties.

James R Dunne1, Mark S Riddle, Janine Danko, Rich Hayden, Kyle Petersen.   

Abstract

Combat casualty care has made significant advances in recent years, including administration of blood products in far-forward locations. However, recent studies have shown blood transfusion to be a significant risk factor for infection and increased resource utilization in critically injured patients. We therefore sought to investigate the incidence of blood transfusion and its association with infection and resource utilization in combat casualties. Prospective data were collected and retrospectively reviewed on 210 critically injured patients admitted to the USNS Comfort over a 7-week period during the 2003 assault phase of Operation Iraqi Freedom. Patients were stratified by age, gender, and injury severity score (ISS). Multivariate regression analyses were used to assess blood transfusion and hematocrit (HCT) as independent risk factors for infection and intensive care unit (ICU) admission controlling for age, gender, and ISS. The study cohort had a mean age of 30 +/- 2 years, a mean ISS of 14 +/- 3, 84 per cent were male, and 88 per cent sustained penetrating trauma. Blood transfusion was required in 44 per cent (n = 93) of the study cohort. Transfused patients had a higher ISS (18 +/- 4 vs. 10 +/- 3, P < 0.01), a higher pulse rate (105 +/- 4 vs. 93 +/- 3, P < 0.0001), and a lower admission HCT (27 +/- 1 vs. 33 +/- 2, P < 0.0001) compared with patients not transfused. Patients receiving blood transfusion had an increased infection rate (69% vs. 18%, P < 0.0001), ICU admission rate (52% vs. 21%, P < 0.0001), and ICU length of stay (6.7 +/- 2.1 days vs. 1.4 +/- 0.5 days, P < 0.0001) compared with nontransfused patients. However, there was no significant difference in mortality between transfused and nontransfused patients. Multivariate binomial regression analysis identified blood transfusion and HCT as independent risk factors for infection (P < 0.01) and blood transfusion as an independent risk factor for ICU admission (P < 0.05). Combat casualties have a high incidence of blood transfusion. Blood transfusion is an independent risk factor for infection and increased resource utilization. Therefore, consideration should be given to the use of alternative blood substitutes and recombinant human erythropoietin in the treatment and management of combat casualties.

Entities:  

Mesh:

Year:  2006        PMID: 16875084

Source DB:  PubMed          Journal:  Am Surg        ISSN: 0003-1348            Impact factor:   0.688


  21 in total

Review 1.  Protocols for massive blood transfusion: when and why, and potential complications.

Authors:  E Guerado; A Medina; M I Mata; J M Galvan; M L Bertrand
Journal:  Eur J Trauma Emerg Surg       Date:  2015-12-09       Impact factor: 3.693

2.  Transfusion of packed red blood cells is not associated with improved central venous oxygen saturation or organ function in patients with septic shock.

Authors:  Brian M Fuller; Mithil Gajera; Christa Schorr; David Gerber; R Phillip Dellinger; Joseph Parrillo; Sergio Zanotti
Journal:  J Emerg Med       Date:  2012-03-24       Impact factor: 1.484

Review 3.  Massive transfusion protocols for patients with substantial hemorrhage.

Authors:  Pampee P Young; Bryan A Cotton; Lawrence T Goodnough
Journal:  Transfus Med Rev       Date:  2011-06-12

Review 4.  Infection-associated clinical outcomes in hospitalized medical evacuees after traumatic injury: trauma infectious disease outcome study.

Authors:  David R Tribble; Nicholas G Conger; Susan Fraser; Todd D Gleeson; Ken Wilkins; Tanya Antonille; Amy Weintrob; Anuradha Ganesan; Lakisha J Gaskins; Ping Li; Greg Grandits; Michael L Landrum; Duane R Hospenthal; Eugene V Millar; Lorne H Blackbourne; James R Dunne; David Craft; Katrin Mende; Glenn W Wortmann; Rachel Herlihy; Jay McDonald; Clinton K Murray
Journal:  J Trauma       Date:  2011-07

5.  The association of early transfusion with acute lung injury in patients with severe injury.

Authors:  Daniel N Holena; Giora Netzer; Russell Localio; Robert J Gallop; Scarlett L Bellamy; Nuala J Meyer; Michael G S Shashaty; Paul N Lanken; Sandra Kaplan; Patrick M Reilly; Jason D Christie
Journal:  J Trauma Acute Care Surg       Date:  2012-10       Impact factor: 3.313

6.  Impact of Operational Theater on Combat and Noncombat Trauma-Related Infections.

Authors:  David R Tribble; Ping Li; Tyler E Warkentien; Bradley A Lloyd; Elizabeth R Schnaubelt; Anuradha Ganesan; William Bradley; Deepak Aggarwal; M Leigh Carson; Amy C Weintrob; Clinton K Murray
Journal:  Mil Med       Date:  2016-10       Impact factor: 1.437

7.  Invasive mold infections following combat-related injuries.

Authors:  Tyler Warkentien; Carlos Rodriguez; Bradley Lloyd; Justin Wells; Amy Weintrob; James R Dunne; Anuradha Ganesan; Ping Li; William Bradley; Lakisha J Gaskins; Françoise Seillier-Moiseiwitsch; Clinton K Murray; Eugene V Millar; Bryan Keenan; Kristopher Paolino; Mark Fleming; Duane R Hospenthal; Glenn W Wortmann; Michael L Landrum; Mark G Kortepeter; David R Tribble
Journal:  Clin Infect Dis       Date:  2012-10-05       Impact factor: 9.079

8.  Early Complications and Outcomes in Combat Injury-Related Invasive Fungal Wound Infections: A Case-Control Analysis.

Authors:  Louis R Lewandowski; Amy C Weintrob; David R Tribble; Carlos J Rodriguez; Joseph Petfield; Bradley A Lloyd; Clinton K Murray; Daniel Stinner; Deepak Aggarwal; Faraz Shaikh; Benjamin K Potter
Journal:  J Orthop Trauma       Date:  2016-03       Impact factor: 2.512

9.  Lessons of war: Combat-related injury infections during the Vietnam War and Operation Iraqi and Enduring Freedom.

Authors:  Dana M Blyth; Heather C Yun; David R Tribble; Clinton K Murray
Journal:  J Trauma Acute Care Surg       Date:  2015-10       Impact factor: 3.313

10.  Tranexamic acid in life-threatening military injury and the associated risk of infective complications.

Authors:  C J Lewis; P Li; L Stewart; A C Weintrob; M L Carson; C K Murray; D R Tribble; J D Ross
Journal:  Br J Surg       Date:  2016-01-21       Impact factor: 6.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.